Jangheung County Mushroom Industry Research Institute hosts a meeting for bio-industry companies as part of the 'Smart Specialization Development Project'.
- 날짜
- 2024.03.27
- Views
- 56
- Manager
- 정동완
Jangheung County Mushroom Industry Research Institute hosted a meeting for representatives from bio-industry companies.
The meeting, held to establish a network for the 'Fungi Bio-Health Material Commercialization Support Project,' was attended by seven bio-industry companies including BRD Korea, Medikos Biotech, Boran Pharma, Poylabs Co., Bio-on-Pack, Korea BM-I, DS Asset Management, as well as four medical and research institutions in Jangheung County, including Jangheung County Mushroom Industry Research Institute.
The purpose of the meeting was to present the current status of each research institution and to discuss material development and collaborative research using fungi and natural substances. Particularly, this meeting provided an opportunity to hear directly from bio-industry companies and to discuss cooperation with research institutions in Jangheung County.
Fungi, with over 10,000 related papers reporting anti-tumor, immune-regulating, antibacterial, and blood pressure-regulating effects, are highly valued as functional materials and are continually being developed for health functional foods, general foods, and cosmetic materials. Jangheung County Mushroom Industry Research Institute is currently establishing the country's only commercialization center for fungi (mushrooms) materials production, which is difficult to apply in existing microbial resource cultivation facilities.
Director Park Seung-bae stated, "Through continuous network building, we will secure potential customers and cooperative partners for the country's only fungi commercialization center and exert efforts in collaborative research for the commercialization of fungal resources."
Source: The article was published by Wejung-sung, a reporter from the Gwangju-Jeonnam branch of the 'Pressian' on September 19, 2023.
--- Translated by ChatGPT ---
The meeting, held to establish a network for the 'Fungi Bio-Health Material Commercialization Support Project,' was attended by seven bio-industry companies including BRD Korea, Medikos Biotech, Boran Pharma, Poylabs Co., Bio-on-Pack, Korea BM-I, DS Asset Management, as well as four medical and research institutions in Jangheung County, including Jangheung County Mushroom Industry Research Institute.
The purpose of the meeting was to present the current status of each research institution and to discuss material development and collaborative research using fungi and natural substances. Particularly, this meeting provided an opportunity to hear directly from bio-industry companies and to discuss cooperation with research institutions in Jangheung County.
Fungi, with over 10,000 related papers reporting anti-tumor, immune-regulating, antibacterial, and blood pressure-regulating effects, are highly valued as functional materials and are continually being developed for health functional foods, general foods, and cosmetic materials. Jangheung County Mushroom Industry Research Institute is currently establishing the country's only commercialization center for fungi (mushrooms) materials production, which is difficult to apply in existing microbial resource cultivation facilities.
Director Park Seung-bae stated, "Through continuous network building, we will secure potential customers and cooperative partners for the country's only fungi commercialization center and exert efforts in collaborative research for the commercialization of fungal resources."
Source: The article was published by Wejung-sung, a reporter from the Gwangju-Jeonnam branch of the 'Pressian' on September 19, 2023.
--- Translated by ChatGPT ---